HCPLive Network
  • AHA 2014
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Wednesday, November 26, 2014
By Adam Hochron
No matter what reason a patient is in the intensive care unit (ICU) of a hospital every moment and medication they take matters in helping them recover. A recent study looked at what dose of systemic corticosteroids should be given to patients with chronic obstructive pulmonary disease (COPD) exacerbations during their time in critical care.
Wednesday, November 26, 2014
By Rachel Lutz
Hepatitis C virus, fibrosis, and cirrhosis patients with sustained virological response can have survival rates comparable to the general population, according to research published in JAMA.
Wednesday, November 26, 2014
New rules announced Tuesday by the U.S. Food and Drug Administration will have many restaurant chains posting calorie counts on their menus, and the rules even apply to movie theater popcorn and ice cream parlor fare.
Wednesday, November 26, 2014
Eating a serving a day of yogurt may lower the risk of developing type 2 diabetes, according to new research published online Nov. 25 in BMC Medicine.
Wednesday, November 26, 2014
A moderate amount of physical activity in daily life may reduce risk of Parkinson's disease, according to a new study published online Nov. 19 in Brain: A Journal of Neurology.
Wednesday, November 26, 2014
The number of emergency department visits in the United States rose from 129.8 million in 2010 to a record 136.3 million in 2011, according to the US Centers for Disease Control and Prevention.
Wednesday, November 26, 2014
For low-income adults with uncontrolled asthma, home visitation by community health workers is associated with improvements in asthma control and quality of life, according to a study published online Nov. 24 in JAMA Internal Medicine.
Tuesday, November 25, 2014
By Rachel Lutz
Glucose intolerances may be linked to non-caloric artificial sweeteners, according to research published in Nature.
Tuesday, November 25, 2014
By Rachel Lutz
Research teams examining the safety and efficacy of zanamivir and oseltamivir for influenza treatment concluded they are not as effective as popularly believed.
Tuesday, November 25, 2014
By Rachel Lutz
HDL cholesterol may have atheroprotective qualities, according to a report from The New England Journal of Medicine.
Tuesday, November 25, 2014
By Amy Jacob
Study results published in the European Respiratory Journal show that rates of inflammatory bowel disease (IBD) incidence have significantly increased in individuals with asthma or chronic obstructive pulmonary disease (COPD).
Tuesday, November 25, 2014
By Amy Jacob
Regeneron Pharmaceuticals, Inc. and Sanofi recently announced the US food and Drug Administration (FDA) granted Breakthrough Therapy designation to dupilumab, a fully-human monoclonal antibody, to treat adults suffering from moderate to severe atopic dermatitis (AD)who had an insufficient response to or who were not suitable for topical prescription therapy.
Email Signup
Breaking News
Onextron (clindamycin phosphate and benzoyl peroxide), 1.2%/3.75%, has been approved for the once-daily treatment of comedonal and inflammatory acne in patients 12 and older.
In the first test of an Ebola virus vaccine in the US, the University of Maryland announced it will soon start human trial.
Hysingla ER (hydrocodone bitartrate) is a single-entity oral hydrocodone tablet that is administered to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Physician's Money Digest
With the advent of ongoing audits for medical necessity and accurate coding, whose documentation is being scrutinized to ensure that the medical services being provided are reasonable and necessary? The answer: physicians.
With the holiday shopping season now upon us, the potential for damaging one’s credit –- either via over-spending or being the victim of identity theft –- is high.
Product News
Obizur (Antihemophilic Factor [Recombinant], Porcine Sequence) has been approved to treat acquired hemophilia A (acquired Factor VIII deficiency), a rare, non-inherited form of hemophilia.
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
The US Food and Drug Administration (FDA) has approved the use of an experimental drug to treat patients who have Ebola Virus Disease.
HCPLive Poll
Twitter Advice
Have you ever given medical or financial advice on Twitter?